AIT Therapeutics, Inc.
AIT Therapeutics, Inc. (AITB) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 12 transactions totaling $236.8K, demonstrating a bearish sentiment with -$236.8K in net insider flow. The most recent transaction on Jan 1, 2019 involved a transaction of 12,000 shares valued at $0.
AITB Insider Activity Summary
Who Is Buying AITB Stock?
No significant insider buying has been recorded for AITB in the recent period.
Who Is Selling AITB Stock?
No significant insider selling has been recorded for AITB in the recent period.
Is AIT Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AITB is bearish with an Insider Alignment Score of 0/100 and a net flow of -$236.8K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
AITB Frequently Asked Questions
Understanding AITB Insider Activity
Insider trading at AIT Therapeutics, Inc. (AITB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading AITB stock, having executed 12 transactions in the past 90 days. The most active insider is Steven A. Lisi (Executive), who has made 3 transactions totaling $497.7K.
Related Tools
Track AIT Therapeutics, Inc. Insider Activity
Get notified when executives and directors at AITB file new Form 4 transactions